These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 20846680)
1. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG; Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917 [TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599 [TBL] [Abstract][Full Text] [Related]
4. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626 [TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349 [TBL] [Abstract][Full Text] [Related]
6. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
8. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322 [TBL] [Abstract][Full Text] [Related]
9. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. Walton TJ; Novara G; Matsumoto K; Kassouf W; Fritsche HM; Artibani W; Bastian PJ; Martínez-Salamanca JI; Seitz C; Thomas SA; Ficarra V; Burger M; Tritschler S; Karakiewicz PI; Shariat SF BJU Int; 2011 Aug; 108(3):406-12. PubMed ID: 21078048 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245 [TBL] [Abstract][Full Text] [Related]
11. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824 [TBL] [Abstract][Full Text] [Related]
13. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510 [TBL] [Abstract][Full Text] [Related]
15. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662 [TBL] [Abstract][Full Text] [Related]
16. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. Xylinas E; Rink M; Margulis V; Faison T; Comploj E; Novara G; Raman JD; Lotan Y; Guillonneau B; Weizer A; Pycha A; Scherr DS; Seitz C; Sun M; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Gönen M; Shariat SF; J Urol; 2013 Feb; 189(2):468-73. PubMed ID: 23253960 [TBL] [Abstract][Full Text] [Related]
17. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy. Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244 [TBL] [Abstract][Full Text] [Related]
18. [Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors]. Izquierdo L; Truán D; Alvarez-Vijande R; Alcaraz A Actas Urol Esp; 2010 Mar; 34(3):232-7. PubMed ID: 20416239 [TBL] [Abstract][Full Text] [Related]
19. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M; BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. Fajkovic H; Cha EK; Jeldres C; Donner G; Chromecki TF; Margulis V; Novara G; Lotan Y; Raman JD; Kassouf W; Seitz C; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Breinl E; Pycha A; Ficarra V; Montorsi F; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Mar; 187(3):845-51. PubMed ID: 22248522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]